Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-27 @ 11:49 PM
Study NCT ID:
NCT06552234
Status:
RECRUITING
Last Update Posted:
2025-11-20
First Post:
2024-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2031-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-01
First Submit QC Date:
None
Study First Post Date:
2024-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-19
Last Update Post Date:
2025-11-20
Last Update Post Date Type:
ESTIMATED